I am amazed at how the price is just pegged so firmly where it is. Five months in the 0.10-0.14 range with the occasional temporary pull up or down. That translates to a company valued at $20-30M.
How does it stay glued here despite massive plans to expand trials and partnerships to Europe while at the same time our cash on hand approaches 0. I still think we'll see some volatility next week but who actually values the company at this level. Either it's much less or much more.
How does it stay glued here despite massive plans to expand trials and partnerships to Europe while at the same time our cash on hand approaches 0. I still think we'll see some volatility next week but who actually values the company at this level. Either it's much less or much more.